Elsevier

Neuropharmacology

Volume 79, April 2014, Pages 101-111
Neuropharmacology

Cooperation of taurine uptake and dopamine D1 receptor activation facilitates the induction of protein synthesis-dependent late LTP

https://doi.org/10.1016/j.neuropharm.2013.10.035Get rights and content

Highlights

  • Neurotransmitters cooperate to promote the conversion of early-LTP into late-LTP.

  • Protein synthesis is fundamental for late-LTP induction.

  • Taurine uptake and D1R activation facilitates late-LTP induction.

  • Different signalling pathways contribute to transform early-LTP into late-LTP.

  • Taurine uptake cooperates with NMDAR and D1R activation in the induction of late-LTP.

Abstract

Co-activation of NMDA and dopamine receptors is required for the induction of the late phase of LTP (L-LTP) that is dependent on new protein synthesis. Other neuromodulatory substances may also contribute to this process. Here, we examined whether taurine is one of the neuromodulators contributing to L-LTP induction, since it is known that taurine uptake induces a long-lasting synaptic potentiation dependent on protein synthesis, and taurine uptake inhibition blocks L-LTP induced by tetanization. Experiments were conducted using rat hippocampal slices where field synaptic potentials were evoked and recorded in CA3-CA1 synapses. Taurine (1 mM) applied 10 min before a high frequency stimulation (HFS) train converted a transitory early-LTP (E-LTP) into an L-LTP dependent on protein synthesis. This taurine effect was blocked by a taurine uptake inhibitor. A facilitation of L-LTP induction was also obtained by pre-application of SKF38393, a D1/D5 dopamine receptor (D1R) agonist. In this case, LTP facilitation was not affected by the taurine uptake inhibitor. Nevertheless, when taurine and SKF38393 were simultaneously pre-applied at a concentration that individually did not modify E-LTP, they produced a synergistic mechanism that facilitated the induction of L-LTP with a sole HFS train. This facilitation of L-LTP was blocked by inhibiting either taurine uptake or D1R activation. Taurine and SKF38393 activated different signaling pathways to transform E-LTP into L-LTP. Taurine-induced L-LTP facilitation required MAPK activation, while D1R-agonist-induced facilitation depended mainly on PKA activation and partially on MAPK activation. On the other hand, the synergistic mechanisms induced by the cooperative action of taurine and SKF38393 were impaired by inhibitors against MAPK, PKA and PI3-K. This pharmacological profile resembles that displayed by L-LTP induced by three HFS trains at 10-min intervals. These results indicate that taurine uptake is necessary and cooperates with other neurotransmitter systems in the induction of L-LTP.

Introduction

Long-term changes in synaptic efficacy are widely used to gain insight into the cellular basis of learning and memory processes. The direction, magnitude and duration of such synaptic modifications depend on the pattern of synaptic stimulation applied, as different stimulation patterns activate different signaling pathways. For example, the protein synthesis-dependent phase of long-term potentiation (L-LTP) is usually evoked by three to four high frequency trains of synaptic stimuli (HFS) spaced 5–10 min apart (Kandel, 2001). A number of studies have demonstrated that L-LTP induction in the hippocampal CA1 region requires dopamine D1R activation (Frey et al., 1991, Huang and Kandel, 1995, Swanson-Park et al., 1999, Granado et al., 2008), and that this type of receptor has to be co-activated with NMDA receptors to be effective (O'Carroll and Morris, 2004, Navakkode et al., 2007, Stramiello and Wagner, 2008). In addition, other neuromodulatory molecules such as noradrenaline, brain-derived neurotrophic factor and nitric oxide (Bailey et al., 2000) might contribute to the coordination of the different signaling pathways involved in the transition from an early phase of LTP (E-LTP) to a more perdurable potentiation phenomenon. However, the exact identity of these neuromodulators and their interactions resulting in L-LTP have not been elucidated.

We found that taurine, a natural amino acid acting as a GABAA and glycine receptor agonist, when applied to rat hippocampal slices, induced a long-lasting potentiation of synaptic efficacy in the CA1 area, by a process independent of the activation of these receptor types (Galarreta et al., 1996). Moreover, LLT-TAU induction was also independent of NMDAR activation (Galarreta et al., 1996, Chepkova et al., 2002). In fact, taurine did not seem to activate glycine site on postsynaptic NMDAR (Suárez and Solís, 2006). Later studies revealed that taurine-induced potentiation requires a taurine uptake process (Sergeeva et al., 2003, del Olmo et al., 2004), which somehow triggers several mechanisms similar to those involved in the maintenance of L-LTP, such as PKA activation and de novo protein synthesis (del Olmo et al., 2003). We previously described that L-LTP induced with multiple high frequency trains of synaptic stimulation was impaired in the presence of an inhibitor of taurine uptake, and this blockade was overcome when the inhibitor was concomitantly applied with taurine (del Olmo et al., 2004). These results demonstrate the possibility that taurine is a key activator of the mechanisms required for L-LTP. Here, we report that pre-application of either taurine before a sole HFS train, which by itself only induces E-LTP, causes a perdurable L-LTP requiring protein synthesis.

Section snippets

Material and methods

The care and use of animals were carried out in accordance with the European Communities Council Directive (86/609/EEC). Protocols were approved by “Comité Ético de Bienestar Animal” at “Hospital Universitario Ramón y Cajal” (animal facilities ES280790002001). All efforts were made to minimize animal suffering and to reduce the number of animals used.

Taurine converts E-LTP into L-LTP

The application of a single HFS train, which normally produces only E-LTP, induces L-LTP in the presence of a D1R agonist (Swanson-Park et al., 1999). We wondered whether taurine could mimic this dopamine-induced facilitation. To this end, we carried out a group of experiments where an HFS train was applied in the presence of 1 mM taurine. To eliminate the effects of taurine through GABA receptors, these experiments were conducted in the presence of 100 μM picrotoxin, a GABAA receptor blocker,

Discussion

Our results show that either taurine uptake or D1R activation promotes the transition process from a single HFS-induced E-LTP into L-LTP. We also show that MAPK activation is required when this process is facilitated by taurine uptake, while L-LTP facilitation by D1R activation requires the contribution of both MAPK and PKA. Moreover, the sub-threshold co-activation of both signaling pathways also converts E-LTP into L-LTP by a synergic mechanism requiring, in addition to MAPK and PKA

Acknowledgments

This work was supported by the “Ministerio de Ciencia e Innovación” (Grant PI08/1067). The authors gratefully acknowledge the technical assistance of José Barbado as well as Jill R. Johnson for proof reading the manuscript.

References (52)

  • R.J. Kelleher et al.

    Translational control by MAPK signalling in long-term synaptic plasticity and memory

    Cell

    (2004)
  • C.H. Lin et al.

    A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amigdala

    Neuron

    (2001)
  • S. Navakkode et al.

    Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro

    Neuropharmacology

    (2007)
  • C.M. O'Carroll et al.

    Heterosynaptic co-activation of glutamatergic and dopaminergic afferents is required to induce persistent long-term potentiation

    Neuropharmacology

    (2004)
  • N. del Olmo et al.

    Taurine-induced synaptic potentiation: role of calcium and interaction with LTP

    Neuropharmacology

    (2000)
  • N. del Olmo et al.

    Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically

    Neuropharmacology

    (2003)
  • K.G. Reymann et al.

    The late maintenance of hippocampal LTP: requirements, phases, “synaptic tagging”, “late-associativity” and implications

    Neuropharmacology

    (2007)
  • K. Sarantis et al.

    Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling

    Neuroscience

    (2009)
  • M. Stramiello et al.

    D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs

    Neuropharmacology

    (2008)
  • J.L. Swanson-Park et al.

    A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation

    Neuroscience

    (1999)
  • K. Yu et al.

    Opposite effects of lead exposure on taurine- and HFS-induced LTP in rat hippocampus

    Brain Res. Bull.

    (2005)
  • K. Abe et al.

    Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes

    J. Neurochem.

    (2001)
  • C.H. Bailey et al.

    Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?

    Nat. Rev. Neurosci.

    (2000)
  • A.N. Chepkova et al.

    Long-lasting enhancement of corticostriatal neurotransmission by taurine

    Eur. J. Neurosci.

    (2002)
  • S.A. Connor et al.

    Conversion of short-term potentiation in mouse CA1 by coactivation of β-adrenergic and muscarinic receptors

    Learn. Mem.

    (2012)
  • S.A. Connor et al.

    Activation of β-adrenergic receptors facilitates heterosynaptic translation-dependent long-term potentiation

    J. Physiol.

    (2011)
  • Cited by (12)

    • <sup>1</sup>H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration

      2017, Neurochemistry International
      Citation Excerpt :

      MPH is known to enhance monoamine function, and this effect is associated with the drug's ability to promote LTP (Jenson et al., 2015). In this regard, it is interesting to note that previous studies have shown that taurine affects dopamine release, and together with dopamine D1 activation promotes LTP, an NMDA receptor-dependent mechanism (Salimäki et al., 2003; Suárez et al., 2014). Hence, it is possible that the MPH-induced upregulation of brain tissue levels of both taurine and aspartate, observed in this study, may be involved in MPH-induced LTP (Jenson et al., 2015).

    • Effects of Methylphenidate on the Dopamine Transporter and Beyond

      2022, Current Topics in Behavioral Neurosciences
    • How the Brain Makes Decisions

      2020, How the Brain Makes Decisions
    View all citing articles on Scopus
    View full text